Abstract
Catheter-associated urinary tract infection (CAUTI) is a major preventable cause of harm for patients in hospital and incurs significant costs for health-care providers such as the UK NHS. Many preventative strategies and measures have been introduced to minimise CAUTI risk, including the use of antimicrobial catheters. However, there is considerable uncertainty regarding their usefulness in terms of reducing symptomatic CAUTI, and whether or not they are cost-effective.
Original language | English |
---|---|
Pages (from-to) | 1-197 |
Number of pages | 197 |
Journal | Health Technology Assessment |
Volume | 16 |
Issue number | 47 |
DOIs | |
Publication status | Published - Nov 2012 |
Keywords
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
- Anti-Infective Agents, Local
- Catheter-Related Infections
- Cost-Benefit Analysis
- Female
- Hospitalization
- Humans
- Male
- Middle Aged
- Nitrofurazone
- Polytetrafluoroethylene
- Quality-Adjusted Life Years
- Silver
- Urinary Catheters
- Urinary Tract Infections
- Young Adult